A candy-flavored amphetamine called Adzenys XR-ODT is being served to children six or older that have been diagnosed with ADHD.
This is questionable because on the label it says that it has a "high potential for abuse and dependence." Why is this being sold to our kids?
This, compounded with a sweet, gummy taste has people in the health industry concerned over possible addiction forming. It has not stopped Neos Therapeutics, the Dallas-based pharmaceutical company that produced the drug, from pushing forward.
According to the company’s CEO, Vipin Garg, he is "launching now at full speed" in an effort to get "ahead of back-to-school season.” What kind of twisted monster wants to dope kids? This should be a last resort medicine.
“The public remains almost entirely ignorant of the fact that methamphetamine produces nearly identical effects to those produced by the popular ADHD medication d-amphetamine (dextroamphetamine). You probably know it as Adderall: a combination of amphetamine and d-amphetamine mixed salts,” wrote Dr. Carl Hart, professor of psychology and psychiatry at Columbia University, in a piece for the Influence.
So what is the FDA thinking? This drug is known to cause fatty liver, heart attack, seizures, stroke, and psychotic episodes. Let's hope no kids eat more than a dose.